Connected profiles2
Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Metabolic Syndrome peptide trials
2 selected ClinicalTrials.gov records carrying the official condition label Metabolic Syndrome. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
Registry records
2 selected records.
Connected peptides
2 profiles.
Registry update years
2026–2026 in selected records.
Indication intelligence
Selected evidence landscape
Trial phases2
Phase labels copied from the retained ClinicalTrials.gov versions.
Phase 2 (1)Phase 4 (1)
Registry statuses2
Overall statuses at each retained observation, not necessarily current today.
Recruiting (1)Enrolling by invitation (1)
Across the connected peptide profiles, PeptideScanner also carries 159 selected PubMed records and 7 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Metabolic Syndrome unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
Record added
ClinicalTrials.gov record NCT06072963
PeptideScanner retained ClinicalTrials.gov record NCT06072963 at 2026-08-10T18:10:03.864Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was semaglutide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- July 27, 2026
- Evidence lane
- Clinical trials
Record added
ClinicalTrials.gov record NCT07707778
PeptideScanner retained ClinicalTrials.gov record NCT07707778 at 2026-08-10T18:10:03.948Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was tirzepatide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- July 20, 2026
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Semaglutide · 2026-07-27
ClinicalTrials.gov record NCT06072963
Recruiting at the retained observation.
Open attributed record →Tirzepatide · 2026-07-20
ClinicalTrials.gov record NCT07707778
Enrolling by invitation at the retained observation.
Open attributed record →